← check another ticker

RXRX
Recursion Pharmaceuticals, Inc.
7
Pretty Regarded
Regard Score: 7/10
$3.00$1.6B market cap
Score Breakdown
🤖AI Rating
6/10Below average.
💸Valuation
5/10Negative cash flow. Can't value it.
P/S: 29.2x
TTM Growth: -59.8%
🔍Filing Risk
5/10Some yellow flags.
Overall Risk: 5/10
Fraud Risk: 0/10
Dilution Risk: 0/10
🖨️Dilution
6/10Shares melting fast.
Annual Dilution: +27.6%
🏃Insider Selling
4/10Neutral.
Signal:
⏳Cash Runway
8/10Tight but ok.
Months Left: 15
🩳Short Interest
9/10Heavy bearish bets.
% of Float Shorted: 44.2%
Days to Cover: 9.3
🤡Management
5/10No data.
Exec Pay (% Rev): 81.5%
🔔 Want to know when RXRX stops being regarded?
Get an email when the regard score changes.
No spam, just alerts.